Vision loss has long been treated as a one-way street, a devastating endpoint rather than a problem the brain might quietly ...

When one eye is deprived of vision early in life, it can lead to amblyopia, a condition more commonly known as lazy eye. This happens because a lack of input disrupts synapse formation in the brain's ...

Please provide your email address to receive an email when new articles are posted on . Advanced Research Projects Agency for Health has launched a program to restore vision through whole eye ...

Scientists have found that an existing drug, already used in humans to treat alcohol use disorder, could help restore vision lost to conditions like age-related macular degeneration and retinitis ...

Please provide your email address to receive an email when new articles are posted on . Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE ...

A clinical trial is investigating whether a stem cell-derived patch can replace disease-damaged cells and restore vision. Age-related macular degeneration is a steadily worsening eye disease and the ...

A radical stem cell transplant has significantly improved the blurry vision of three people with severe damage to their cornea. The clinical trial, which took place in Japan, is the first of its kind ...

For some degenerative vision disorders, the therapies available don’t restore sight, they mainly slow its decline. To realize this benefit, a patient must receive an eye injection as frequently as ...

People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes and a pair of high-tech glasses. Age-related macular degeneration (AMD) is a ...

The case marks the first time sight has been partially restored using optogenetics, a type of biological research aimed at controlling nerve cells via light. Jackson Ryan was CNET's science editor, ...

Elon Musk recently pronounced that the next Neuralink project will be a “Blindsight” cortical implant to restore vision: “Resolution will be low at first, like early Nintendo graphics, but ultimately ...

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. RV-001 a gene-agnostic approach for RP patients.